Glaukos (GKOS) Invested Capital (2014 - 2021)

Glaukos (GKOS) posted quarterly Invested Capital of $279.3 million for Q2 2021, little changed quarter-over-quarter from $279.0 million in Q1 2021.

Glaukos (GKOS) Invested Capital (2014 - 2021) Analysis & Trends

Glaukos (GKOS) has reported Invested Capital for 5 consecutive years, with $279.3 million the latest figure, recorded in Q2 2021.

In Q2 2021, Invested Capital changed N/A year-over-year to $279.3 million; the TTM figure through Mar 2022 stood at $279.3 million (down 24.13% YoY), while the FY2020 annual figure was $89.2 million, changed N/A from the prior year.
Invested Capital was little changed at $279.3 million in Q2 2021 per GKOS's latest filing, from $279.0 million in the prior quarter.
Across five years, Invested Capital topped out at $279.3 million in Q2 2021 and bottomed at $89.2 million in Q4 2020.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Invested Cap. (Qtr)
1	Abbott Laboratories	199.44 Bn	193.84 Bn	7.27 Bn	3.01 Bn
2	Stryker	127.32 Bn	123.85 Bn	4.50 Bn	750.00 Mn
3	Medtronic	118.87 Bn	109.65 Bn	6.41 Bn	1.79 Bn
4	Boston Scientific	73.47 Bn	72.93 Bn	3.85 Bn	1.71 Bn
5	Edwards Lifesciences	51.90 Bn	47.65 Bn	1.35 Bn	-
6	Dexcom	34.30 Bn	32.36 Bn	830.00 Mn	-
7	GE HealthCare Technologies	33.74 Bn	31.63 Bn	2.18 Bn	2.00 Mn
8	Koninklijke Philips	26.35 Bn	23.03 Bn	4.55 Bn	1.34 Bn
9	Steris	23.05 Bn	22.56 Bn	684.20 Mn	243.40 Mn
10	Glaukos	10.81 Bn	10.70 Bn	151.59 Mn	-

Download Data